mechanism of glp-1 receptor agonists A Closer Look at the Dermatological Profile List of GLP-1 Receptor Agonists

Challa TD, Beaton N, Arnold M, Rudofsky G, Langhans W, Wolfrum C

Figure 1 Conflict of interest statement The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest

ALOX15 aggravates metabolic dysfunction-associated steatotic liver disease in mice with type 2 diabetes via activating the PPAR/CD36 axis

**The listing of a company (e.g., Novo Nordisk, Eli Lilly) or product (e.g., Ozempic, Mounjaro, Wegovy, Rybelsus, Trulicity, Saxenda or Zepbound) is not meant to state or imply that the company acted illegally or improperly or that the product is unsafe or defective

Gibble TH, Cao D, Forrester T, et al

While for others, their standard supplier qualification has been sufficient